Optimal Control of a Tumor-Immune System with a Modified Stepanova Cancer Model

被引:0
|
作者
Dassow, Maria [1 ]
Djouadi, Seddik [1 ]
Moussa, Kaouther [2 ]
机构
[1] Univ Tennessee, Knoxville, TN 37996 USA
[2] Univ Grenoble Alpes, CNRS, Grenoble INP, GIPSA Lab, F-38000 Grenoble, France
来源
IFAC PAPERSONLINE | 2021年 / 54卷 / 15期
关键词
cancer; chemotherapy; immunotherapy; drug delivery; biological systems; optimization; Pontryagin's Maximum Principle; CHEMOTHERAPY;
D O I
10.1016/j.ifacol.2021.10.260
中图分类号
TP [自动化技术、计算机技术];
学科分类号
0812 ;
摘要
In this paper, we investigate strategies for administering chemo- and immunotherapy to force a tumor-immune system to its healthy equilibrium. To solve this problem, we use Pontryagin's Maximum Principle applied to a modified Stepanova model. This model directly accounts for the detrimental effects of chemotherapy on immune cell density. Because the parameter for this interaction is unknown, we run simulations while varying the parameter to observe the effect on the system. Our results show that combined dosages of chemo- and immunotherapy over the first days of the treatment period are sufficient to force the system to its healthy equilibrium. Copyright (C) 2021 The Authors.
引用
收藏
页码:227 / 232
页数:6
相关论文
共 50 条
  • [41] Optimal control problem for a general reaction-diffusion tumor-immune interaction system of mixed immunotherapy and chemotherapy
    Dai, Feng
    Liu, Bin
    EUROPEAN JOURNAL OF CONTROL, 2022, 66
  • [42] The stability analysis of tumor-immune responses to chemotherapy system with gaussian white noises
    Duan, Wei-Long
    Fang, Hui
    Zeng, Chunhua
    CHAOS SOLITONS & FRACTALS, 2019, 127 : 96 - 102
  • [43] Laser immunotherapy and the tumor-immune system interaction: a mathematical model and analysis
    Laverty, Sean M.
    Dawkins, Bryan A.
    Chen, Wei R.
    BIOPHOTONICS AND IMMUNE RESPONSES IX, 2014, 8944
  • [44] Signatures of tumor-immune interactions as biomarkers for breast cancer prognosis
    Manjili, Masoud H.
    Najarian, Kayvan
    Wang, Xiang-Yang
    FUTURE ONCOLOGY, 2012, 8 (06) : 703 - 711
  • [45] Bistability in a model of tumor-immune system interactions with an oncolytic viral therapy
    Vithanage, G. V. R. K.
    Wei, Hsiu-Chuan
    Jang, Sophia R-J
    MATHEMATICAL BIOSCIENCES AND ENGINEERING, 2022, 19 (02) : 1559 - 1587
  • [46] Optimal Treatment Strategy for a Tumor Model under Immune Suppression
    Kim, Kwang Su
    Cho, Giphil
    Jung, Il Hyo
    COMPUTATIONAL AND MATHEMATICAL METHODS IN MEDICINE, 2014, 2014
  • [47] Application of scaling and sensitivity analysis for tumor-immune model reduction
    Kiran, Kanchi Lakshmi
    Lakshminarayanan, S.
    CHEMICAL ENGINEERING SCIENCE, 2011, 66 (21) : 5164 - 5172
  • [48] Angiogenesis inhibition and tumor-immune interactions with chemotherapy by a control set-valued method
    Kassara, K.
    Moustafid, A.
    MATHEMATICAL BIOSCIENCES, 2011, 231 (02) : 135 - 143
  • [49] DYNAMICS OF A MODEL OF TUMOR-IMMUNE INTERACTION WITH TIME DELAY AND NOISE
    Han, Lifeng
    He, Changhan
    Kuang, Yang
    DISCRETE AND CONTINUOUS DYNAMICAL SYSTEMS-SERIES S, 2020, 13 (09): : 2347 - 2363
  • [50] Understanding the tumor-immune microenvironment in prostate cancer
    Dong, Liang
    Myers, Kayla, V
    Pienta, Kenneth J.
    CURRENT OPINION IN ONCOLOGY, 2021, 33 (03) : 231 - 237